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518Objective: The purpose of this study was to investigate the feasibility and safety of pulmonary valve implan-
tation via direct right ventricle puncture.
Methods: A standard thoracotomy and direct right ventricle puncture were performed in 8 healthy sheep to im-
plant the pulmonary valve stents. Animals were followed up for 18 months.
Results: Three sheep died within the first 4 months after stent placement. The remaining 5 animals survived.
After 18 months, examinations by color echocardiography, 64-slice computed tomography scan, and cardiac
catheter showed an ideal position of each stent. The function of the pulmonary valves and hearts was not differ-
ent compared with the preoperative conditions of the sheep. Anatomic examination revealed that the stent was
covered by a layer of endothelial tissue with no stent fracture or valvular calcification. The histologic evaluation
of the stent and surrounding tissue showed that the surface of the stent was smooth and covered by a complete
layer of endothelial cells without obvious infiltration of inflammatory cells. The vascular wall was integrative
without tear phenomenon in each layer of tissue.
Conclusions: These results show that pulmonary valve stents can be implanted via direct right ventricle punc-
ture. Further studies evaluating xenograft valve material and the effect of implantation in vivo are needed. (J
Thorac Cardiovasc Surg 2011;141:518-22)Since Bonhoeffer and colleagues1 successfully performed
percutaneous pulmonary valve replacement in a 12-year--
old boy with right ventricular outflow tract (RVOT) stenosis
and pulmonary valve insufficiency in October 2000, a flurry
of clinical and experimental percutaneous valve replace-
ment studies ensued.2-4 Today, these studies continue to
be popular.5,6 Because the diameter of the sheath for
implanting valve stents is relatively large, it is easy to
damage the peripheral veins, particularly in pediatric
patients.7 In addition, this approach can also damage the
heart chambers, resulting in cardiac tamponade.8 The
sheath needs to be manipulated to a certain degree to ensure
the stent is ultimately placed in the correct position. There-
fore, to avoid extracorporeal circulation in cardiac surgery
and to prevent damage to the peripheral blood vessels or
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The Journal of Thoracic and Cardiovascular Surgous valve replacement, the efficacy of pulmonary valve
implantation via direct right ventricle puncture was
investigated.
MATERIALS AND METHODS
Pulmonary Valve Stent
The pulmonary valve stent was constructed with an artificial valve
and a conduit-shaped stent as previously reported9,10 and shown in
Figure 1, A and B.
Animals
Eight healthy sheep (5male and 3 female), weighing an average of 23.5
3.1 kg, were used. No abnormalities were found by preoperative electrocar-
diography, thoracic radiography, and color echocardiography examinations.
Animals were deprived of water and food for 10 hours preoperatively. Ani-
mals were anaesthetized initially by intramuscular injection of ketamine (10
mg/kg body weight), followed by an intravenous injection of vecuronium
bromide (2 mg). All animals were intubated and ventilated during the proce-
dure. Propofol (0.2 mg/kg/min) was administered intravenously by a contin-
uous rate infusion to maintain the anesthetic condition. All animals received
care in compliance with the Guide for the Care and Use of Laboratory An-
imals, published by The National Academies in 1988.Valve Stent Implantation and Postoperative
Treatment
A 10-cm incision was made in the subxiphoid, and a lower partial ster-
notomywas performed. The pericardiumwas suspended, and the right ven-
tricular freewall was exposed. An echocardiography transducer was placed
directly on the main pulmonary artery to measure the diameter of the pul-
monary artery throughout the procedure. The size of the stent was selected
on the basis of the diameter ratio of the pulmonary artery to the stent lumen.
The desired ratio was 1:1.1. A purse-string suture was placed in the anterior
wall of the right ventricle near its apex. A sheathwas punctured directly intoery c February 2011
FIGURE 2. Valved stent completely crimped into a 14F sheath.
TABLE 1. Surgical information on implantations performed in
experimental sheep
Abbreviations and Acronyms
H&E ¼ hematoxylin-eosin
RVOT ¼ right ventricular outflow tract
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flow tract. The delivery route for the stent was established by introducing
a J-type steel guidewire via the sheath (Figure 2, B). The entire procedure
was performed under transthoracic echocardiography guidance. The posi-
tion of the guidewire could be noted when it made contact with the pulmo-
nary artery wall. The guidewire was subsequently advanced into the distal
segment of the left or right pulmonary artery. The sheath was withdrawn,
and a 10F expandable sheath was deployed into the right ventricle via the
guidewire to expand the puncture hole. After the expandable sheath was re-
moved, a 14F delivery sheathwith a nickel-titaniumvalve stentwas inserted
into the pulmonary artery via the guidewire. After confirming that the stent
had been placed in the optimal position under echo guidance, the delivery
sheath and guidewire were removed. The purse-string suture was tied.
Echocardiography was performed to evaluate the prosthetic valve function
and hemodynamic function. The thoracic cavity was then closed.
After the procedure, all animals were given an intramuscular injection
with penicillin (800,000 units) and subcutaneous injections of low molec-
ular heparin (2500 IU) for 3 days. Oral aspirin (3 mg/kg body weight) was
given for 30 days.
Anatomic Study Immediately After Valve Stent
Implantation
Right ventricular angiography was performed in the animals with suc-
cessful valve stent implantation to assess the stent position. One sheep
with ideal valve stent implantation was sacrificed by femoral artery bleed-
ing 12 hours postoperatively. The right ventricle was opened to observe the
stent position and structure of the surrounding tissues.
Angiography and Anatomic Examination 18 Months
After Stent Implantation
The remaining sheep underwent right ventricle angiography to evaluate
the stent position 18months after implantation under digital subtraction an-
giography (Siemens, Munich, Germany). In addition, 64-slice enhanced
computed tomography scans were performed in 2 animals.
Surviving sheep were sacrificed at 18 months by femoral artery bleed-
ing. Pulmonary arterial tissues were collected for histologic examination.
Some tissue samples containing nitinol wire were plastic-embedded,
sliced with a gold stainless-steel microtome blade, and stained with
hematoxylin–eosin (H&E). Samples that did not contain nitinol wire
were paraffin-embedded, sectioned, and stained with H&E.FIGURE 1. Pulmonary valve stent construction, A, Anterior view of pul-
monary valve stent. B, Lateral view of pulmonary valve stent.
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Operative Success
Eight sheep underwent stent placement. In 1 sheep, the stent
was too small and dropped into the right ventricle. The animal
died of severe bleedingwhen the stentwaswithdrawn from the
right ventricle. Stent implantation was successful in the re-
maining 7 sheep; however, 1 sheep died 3 hours postopera-
tively, presumably of anesthesia-related complications.
Another sheep had shortness of breath and exercise intolerance
postoperatively.Despite 7 days of diuretic treatment, this sheep
died (4 months postoperatively), and thrombosis in the proxi-
mal region of the stent was identified on postmortem examina-
tion. All remaining 5 animals survived. One animal was
sacrificed 12 hours postoperatively. The remaining 4 sheep
recovered and resumed a normal diet and preoperative level
within 3 to 5 days after the operation.
Intraoperative echocardiography performed after stent
placement identified a pulmonary artery diameter of 14.7
 0.8 mm and a stent lumen diameter of 19.1  1.6 mm.
The operation duration was 85.4  6.6 minutes (Table 1).Angiography and Anatomy Examination of the Valve
Stent Immediately After Implantation
The position of the stent was ideal in all sheep. Right
ventricular angiography (performed immediately before
recovery) showed that the stent in 1 sheep was implanted
near the RVOT. The end and neck of the stent had obvious
contraction and relaxation with the outflow tract (Figure 3,
A and B).
Twelve hours postoperatively, no hematoma or bleeding
was identified in the pocket of the right ventricle in theID
Pulmonary valve annulus
ultrasound (mm)
Diameter of
stent (mm)
Operation
time (min)
1 14.1 18 85
2 13.8 18 95
3 15.6 22 75
4 15.4 20 80
5 15.2 20 90
6 14.8 18 85
7 13.7 18 88.
8* — — —
Mean 14.7 19.1 85.4
SD 0.8 1.6 6.6
Minimum 13.6 18 75
Maximum 15.6 22 95
SD, Standard deviation. *Implantation of valved stent failed in sheep number 8.
rdiovascular Surgery c Volume 141, Number 2 519
FIGURE 3. Valved stent contracted and relaxed with RVOT contraction. A, One implanted stent contracted with RVOT contraction. The diameter of the
stent neck is similar to the diameter of the pigtail catheter tip. B, The same stent relaxed with RVOT relaxation. The diameter of the stent neck is bigger than
the diameter of the pigtail catheter tip.
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The pulmonary valve stent was placed in a good position;
the proximal stent flare was fixed at the beginning of the
main pulmonary artery and fit perfectly in the RVOT with
no impact on tricuspid valve function. The original pulmo-
nary valve was compressed tightly, and no space remained
between the stent and the pulmonary arterial wall. There
was no thrombosis in the prosthetic valve, and no obvious
damage was evident in the RVOTor main pulmonary artery.
Angiography and Anatomy Examination of the Valve
Stent 18 Months Postoperatively
Anatomic study in 4 sheep performed 18 months postop-
eratively revealed a normal tissue covering the sutures in the
right ventricle (Figure 4, B). The stents were in ideal posi-
tions and covered by a layer of endothelial tissue
(Figure 4, C). The leaves of the prosthetic valve were intact
and soft with no evidence of excrescence (eg, thrombosis),
calcification, or damage. The sutures on the valve ring and
stents themselves were covered by endothelial tissue. No
fracture was noted in any stent.FIGURE 4. Anatomic study performed postoperatively. A, No hematoma or ble
postoperatively. B, Anatomic study performed 18 months postoperatively reveal
were covered by a layer of endothelial tissue.
520 The Journal of Thoracic and Cardiovascular SurgA 64-slice computed tomography scan was performed in
2 of the 4 animals, showing patent stents in good positions
(Figure 5).
Anatomy examination performed 18 months postopera-
tively revealed no valvular calcification. The tissues stained
with H&E showed that the nitinol wires of the stent were
smooth and covered by a complete layer of endothelial cells
(Figure 6, A and B). Fibrous tissue hyperplasia was noted in
the surrounding area without significant inflammatory reac-
tion. The H&E-stained pulmonary artery tissue sections that
did not contain nitinol wire showed no significant infiltra-
tion of inflammatory cells (Figure 6, C andD). The vascular
wall was integrative without tear phenomenon in each layer
of tissue.
DISCUSSION
Our research group previously reported successful percu-
taneous pulmonary valve replacement by pulmonary valve
stent.5 After a 6-month follow-up period, the outcome was
good. Because the peripheral blood vessels are small in pe-
diatric patients and can be easily damaged during theedingwas identified in the pocket of the right ventricle in the sheep 12 hours
ed a normal tissue covering over the sutures in the right ventricle. C, Stents
ery c February 2011
FIGURE 5. Multislice computed tomography scan further confirmed the
desired position of the valved stent 18 months after implantation.
Zong et al Evolving Technology/Basic Scienceinsertion of a rough sheath, a minimally invasive surgical
method for pulmonary valve replacement via transcatheter
thoracotomy could be considered a viable alternative.11 In
this study, sheep underwent pulmonary valve replacement
via transcatheter thoracotomy and were followed up for an
18-month period postoperatively. The results of this pilotFIGURE 6. A and B, H&E-stained pulmonary tissues containing nitinol wires
(340) show a smooth surface of nitinol wire. C, H&E-stained pulmonary arter
stained pulmonary artery tissue without nitinol wire shows no significant infiltr
The Journal of Thoracic and Castudy confirm the possibility and reliability of this surgical
procedure.
The procedure is performed on the beating heart via right
ventricular puncture, exchanging an expandable sheath, and
inserting a pulmonary valve stent to finally release the re-
placement stent. During the operation, color echocardiogra-
phy is used to measure the diameter of the pulmonary artery
and guide the stents to ensure appropriate positioning.
The anatomic study performed 12 hours postoperatively
indicated that the stents were ideally placed and fixed prop-
erly with no damage to the arterial wall. The study also con-
firmed that the stent design was reasonable for replacing the
original valve with a prosthetic valve. In addition, the oper-
ation had no significant impact on cardiac structure. We
suggest that this is a feasible technique for clinical practice.
The anatomic study performed 18 months postoperatively
showed that the ventricular puncture was fully healed and
that the stents were in good condition.
One animal had right ventricular failure 4 months after
the operation. The animal did not respond to diuretic treat-
ment and finally died of thrombosis in the proximal region
of the stent. The possible cause for this development may be
related to the low pressure in the right side of the heart,
which ultimately increases the risk of thrombosis in the
stent or prosthetic valve. In addition, this animal was ad-
ministered an antiplatelet drug for only 1 month, which
may not have been adequate to prevent thrombosis afterand surrounding tissues sliced with a gold stainless-steel microtome blade
y wall (3200) shows non-tear phenomenon of the vascular wall. D, H&E-
ation of inflammatory cells.
rdiovascular Surgery c Volume 141, Number 2 521
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ticoagulation treatment with warfarin in clinical practice
should be considered. At present, there are no reports
regarding anticoagulation treatment for prosthetic nickel-
titanium valve stent implantation. This topic could benefit
from further investigations to improve the long-term safety
of valve replacement.12
The stent was placed in the RVOT in 1 sheep. Because the
outflow tract is a muscular structure, it can contract and re-
lax along with the heart, which may result in metal fatigue
after a certain (unspecified) period of time and ultimately
lead to the possibility of stent fracture. Theoretically, the
original pulmonary valve is the most ideal place for stent
positioning; however, in practice, stents are sometimes im-
planted in an unplanned location regardless of whether
color echocardiography or digital subtraction angiography
is used to assist in stent positioning. No adverse effects
caused by this stent location problem were noted in this
sheep for the duration of the study period. The anatomic
study performed 18 months postoperatively showed no ev-
idence of stent fracture that might be related to the stent wir-
ing technique used in this study. These results indicate that
a small amount of position deviation is not likely to cause
any serious complications, perhaps because there are no
important anatomic structures in this area that can be
negatively affected by a wrongly placed stent, such as the
initiation of the coronary artery.CONCLUSIONS
Although this is a pilot study, some specific limitations are
worth mentioning. The prosthetic valve selected for this ex-
periment was derived from sheep pericardium and is not
practicable in the clinical setting. Therefore, it is necessary
to perform studies to evaluate xenograft valve material and
the effect of implantation in vivo. Second, the valved stent522 The Journal of Thoracic and Cardiovascular Surgwas placed in the native pulmonary artery with a soft wall.
Sheep anatomy is dissimilar to that of humans. There was
no animal model to mimic a right ventricular-pulmonary
artery conduit in this study. Specifically, some patients
have largeRVOTs after transannular patch repair of tetralogy
of Fallot, and the size of the stent should be larger for these
patients. Further studies should attempt to create a similar,
simple, and reproducible animal model. The small sample
size in our study is also an obvious limitation.
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